TNYA - Tenaya Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

202.4M

Cash

122.2M

Avg Qtr Burn

-25.11M

Short % of Float

7.88%

Insider Ownership

1.12%

Institutional Own.

71.89%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
TN-201 Details Hypertrophic cardiomyopathies	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TN-401 Details Arrhythmogenic Right Ventricular Cardiomyopathy	Phase 1b Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TN-301 Details Heart failure	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.